ORASURE TECHNOLOGIES INC
8-K, EX-99, 2000-12-18
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: ORASURE TECHNOLOGIES INC, 8-K, 2000-12-18
Next: BODYGUARD RECORDS COM INC, SB-2/A, 2000-12-18




Exhibit 99

[GRAPHIC OMITTED]


Company Contacts:

Michelle Sells              Rich Hooper
Manager, Investor Relations Vice President,
                            Finance
503-641-6115                610-882-1820
[email protected]
www.orasure.com



                  OraSure Technologies Sets Annual Meeting Date


BEAVERTON,  Ore.  (December 15, 2000) - OraSure  Technologies,  Inc. (Nasdaq NM:
OSUR)  today  announced  that as a result of  changing  from a fiscal  year to a
calendar year ending December 31 for financial reporting  purposes,  the Company
has changed the date set for its next annual meeting of stockholders to June 14,
2001. The meeting will take place in Bethlehem, PA, which is now the location of
the executive offices for OraSure.  A specific meeting site will be communicated
to  stockholders  in the proxy  materials  distributed  for the annual  meeting.
Stockholder  proposals must be received prior to January 15, 2001 in order to be
considered  for  inclusion  in the  Company's  proxy  statement  under  relevant
Securities and Exchange Commission rules and prior to April 25, 2001 in order to
be  considered  at the annual  meeting or to nominate a Director  under  OraSure
Technologies' Bylaws.

About OraSure

OraSure  Technologies,  Inc. develops,  manufactures and markets medical devices
and diagnostic products for use by public- and private-sector clients,  clinical
laboratories, physicians' offices and workplace testing. OraSure Technologies is
the  leading  supplier of oral fluid  collection  devices and assays to the life
insurance  industry and public health markets for the detection of antibodies to
HIV-1.  In addition,  the company  supplies  oral fluid  testing  solutions  for
drugs-of-abuse  testing.  For  more  information  on the  company  please  go to
www.orasure.com.

[PRESS RELEASE]



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission